Sandostatin LAR Depot
NDC 0078-0825, octreotide acetate, kit, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0825
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021008
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0825-81 | 00078082581 | 1 KIT in 1 KIT (0078-0825-81) * 2 mL in 1 SYRINGE * 6 mL in 1 VIAL (0078-0804-61) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d0b7fe9e-7000-4b79-ba3b-291ce92c14f9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0078-0825NADAC price for package 00078082581
GET /v1/drugs/nadac/00078082581
Use it
Look up 0078-0825 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.